Cargando…

Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma

PURPOSE: To investigate the effect and complications of Combined Endoscope assisted Procedures (CEaP): endoscopic cyclophotocoagulation and pars plana ablation (ECP-plus), along with endoscopic panretinal photocoagulation (PRP). PATIENTS AND METHODS: The study design is a retrospective and noncompar...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yuan-Shao, Lin, Shih-Huan, Chang, Chia-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299373/
https://www.ncbi.nlm.nih.gov/pubmed/32555597
http://dx.doi.org/10.1371/journal.pone.0234798
_version_ 1783547373706805248
author Cheng, Yuan-Shao
Lin, Shih-Huan
Chang, Chia-Jen
author_facet Cheng, Yuan-Shao
Lin, Shih-Huan
Chang, Chia-Jen
author_sort Cheng, Yuan-Shao
collection PubMed
description PURPOSE: To investigate the effect and complications of Combined Endoscope assisted Procedures (CEaP): endoscopic cyclophotocoagulation and pars plana ablation (ECP-plus), along with endoscopic panretinal photocoagulation (PRP). PATIENTS AND METHODS: The study design is a retrospective and noncomparative interventional case series from a tertiary referral center in Taiwan. Patients experiencing vessel growth at the iris and anterior chamber angle, along with an IOP > 21 mmHg were included. RESULTS: Twenty-five eyes from 23 patients were included over a 24-month period. After the procedures, all of them had a lower IOP value than their preoperative value. The mean IOP was 38.2± 7.1 mm Hg preoperatively, and 10.2± 4.7 mmHg (1 day), 13.8± 4.6 mmHg (1 week), 15.0± 5.3 mmHg (2 weeks), 17.4± 4.7 mmHg (1 month), 16.6± 4.1 mmHg (3 months), 16.0± 5.0 mmHg (6 months), and 15.7± 5.5 mmHg (12 months) postoperatively. At the 6th and 12th months, the IOP stabilized rate was 84% and 75%, respectively. Complications in the initial postoperative period (< 3 months) included uveitis (24%), and hyphema (16%), which were both resolved in the early postoperative period. Complications beyond 6 months included hypotony and phthisis bulbi in two patients (8%) in our study. There was no subject who suffered from retinal detachment, endophthalmitis or any other severe complications. CONCLUSIONS: The results of this study show that CEaP offers positive results in IOP lowering and NV regression. Additionally, CEaP is a complete treatment for NVG in controlling IOP and NV growth. The IOP lowering effects can be sustained upon completion of the treatment.
format Online
Article
Text
id pubmed-7299373
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72993732020-06-19 Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma Cheng, Yuan-Shao Lin, Shih-Huan Chang, Chia-Jen PLoS One Research Article PURPOSE: To investigate the effect and complications of Combined Endoscope assisted Procedures (CEaP): endoscopic cyclophotocoagulation and pars plana ablation (ECP-plus), along with endoscopic panretinal photocoagulation (PRP). PATIENTS AND METHODS: The study design is a retrospective and noncomparative interventional case series from a tertiary referral center in Taiwan. Patients experiencing vessel growth at the iris and anterior chamber angle, along with an IOP > 21 mmHg were included. RESULTS: Twenty-five eyes from 23 patients were included over a 24-month period. After the procedures, all of them had a lower IOP value than their preoperative value. The mean IOP was 38.2± 7.1 mm Hg preoperatively, and 10.2± 4.7 mmHg (1 day), 13.8± 4.6 mmHg (1 week), 15.0± 5.3 mmHg (2 weeks), 17.4± 4.7 mmHg (1 month), 16.6± 4.1 mmHg (3 months), 16.0± 5.0 mmHg (6 months), and 15.7± 5.5 mmHg (12 months) postoperatively. At the 6th and 12th months, the IOP stabilized rate was 84% and 75%, respectively. Complications in the initial postoperative period (< 3 months) included uveitis (24%), and hyphema (16%), which were both resolved in the early postoperative period. Complications beyond 6 months included hypotony and phthisis bulbi in two patients (8%) in our study. There was no subject who suffered from retinal detachment, endophthalmitis or any other severe complications. CONCLUSIONS: The results of this study show that CEaP offers positive results in IOP lowering and NV regression. Additionally, CEaP is a complete treatment for NVG in controlling IOP and NV growth. The IOP lowering effects can be sustained upon completion of the treatment. Public Library of Science 2020-06-17 /pmc/articles/PMC7299373/ /pubmed/32555597 http://dx.doi.org/10.1371/journal.pone.0234798 Text en © 2020 Cheng et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Cheng, Yuan-Shao
Lin, Shih-Huan
Chang, Chia-Jen
Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma
title Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma
title_full Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma
title_fullStr Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma
title_full_unstemmed Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma
title_short Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma
title_sort combined endoscope assisted procedures (ceap) as a complete treatment for neovascular glaucoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299373/
https://www.ncbi.nlm.nih.gov/pubmed/32555597
http://dx.doi.org/10.1371/journal.pone.0234798
work_keys_str_mv AT chengyuanshao combinedendoscopeassistedproceduresceapasacompletetreatmentforneovascularglaucoma
AT linshihhuan combinedendoscopeassistedproceduresceapasacompletetreatmentforneovascularglaucoma
AT changchiajen combinedendoscopeassistedproceduresceapasacompletetreatmentforneovascularglaucoma